Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2020 Earnings

30SepConfirmed

Dec 19

Mar 20

Jul 20

Q2 2020

-0.19

-0.13

-0.06

0

Details

Expected EPS

0

Actual EPS

-0.0818

Surprise EPS

-0.08

Surprise Percent

+∞%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.0818 per share for Q2 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.